Abstract:SUMMARYThe stabilities of B77 avian sarcoma virus intracellular RNAs were compared to the stability of the total cellular poly(A)-containing RNA by labelling infected chicken embryo fibroblasts with [3H]uridine for 15 h, adding actinomycin D (1 ~tg per ml) to block further transcription of viral RNA, and selecting virus-specific RNA from the total cellular poly(A)-containing RNA at 3 hourly intervals. The three virus-specific RNA species (9-3, 3.3 and 5.4 kilobases) decayed with half-lives of 7-5, 10, and 15 h… Show more
“…Instead HIV-1 unspliced RNA constitutes a single functional pool that can function interchangeably as mRNA and as vpRNA. Our results are similar to results with ASV and RSV in which Stoltzfus et al (23) and Sonstegard and Hackett (22) concluded that a single metabolic pool of viral RNA exists that functions as both mRNA and vpRNA. Contrasting results in the MLV system suggested that there are two nonequilibrating pools of MLV RNA, each functioning as either mRNA or vpRNA (11).…”
Section: Discussionsupporting
confidence: 91%
“…These data implied that MLV transcripts segregate into two functionally distinct populations of mRNA for translation or vpRNA for encapsidation (11). Stoltzfus et al (23) applied isotopic equilibrium assay to cells infected with avian sarcoma virus (ASV) and observed not two but rather a single RNA population that functions as both ASV mRNA and vpRNA. Sonstegard and Hackett (22) came to similar conclusions in their studies of Rous sarcoma virus (RSV) vector RNAs.…”
The retroviral primary transcription product is a multifunctional RNA that is utilized as pre-mRNA, mRNA, and genomic RNA. The relationship between human immunodeficiency virus type 1 (HIV-1) unspliced transcripts used as mRNA for viral protein synthesis and as virion precursor RNA (vpRNA) for encapsidation remains an important question. We developed a biochemical assay to evaluate the hypothesis that prior utilization as mRNA template for protein synthesis is necessary to generate vpRNA. HIV-1-infected T cells were treated with translation inhibitors under conditions that maintain virus production. Immunoprecipitation of newly synthesized HIV-1 Gag protein revealed that de novo translation is not necessary to sustain assembly, release, or processing of Gag structural protein. Both newly synthesized protein and steady-state Gag are competent for assembly, and the extracellular accumulation of Gag is proportional to the intracellular abundance of Gag. As early as 2 h after transcription, newly synthesized RNA is detectable in cell-free virions and encapsidation is sustained upon inhibition of host cell translation. Results of both [ 3 H]uridine incorporation assays and HIV-1-specific RNase protection assays (RPAs) indicate that translation inhibition reduces the absolute amounts of both cytoplasmic and virion-associated RNA. Evaluation of encapsidation efficiency by RPA revealed that the cytoplasmic availability of vpRNA is increased, indicating that HIV-1 unspliced mRNA can be rerouted to function as vpRNA. Our data contrast with results from the HIV-2 and murine leukemia virus systems and indicate that HIV-1 unspliced RNA constitutes a single functional pool that can function interchangeably as mRNA and as vpRNA.
“…Instead HIV-1 unspliced RNA constitutes a single functional pool that can function interchangeably as mRNA and as vpRNA. Our results are similar to results with ASV and RSV in which Stoltzfus et al (23) and Sonstegard and Hackett (22) concluded that a single metabolic pool of viral RNA exists that functions as both mRNA and vpRNA. Contrasting results in the MLV system suggested that there are two nonequilibrating pools of MLV RNA, each functioning as either mRNA or vpRNA (11).…”
Section: Discussionsupporting
confidence: 91%
“…These data implied that MLV transcripts segregate into two functionally distinct populations of mRNA for translation or vpRNA for encapsidation (11). Stoltzfus et al (23) applied isotopic equilibrium assay to cells infected with avian sarcoma virus (ASV) and observed not two but rather a single RNA population that functions as both ASV mRNA and vpRNA. Sonstegard and Hackett (22) came to similar conclusions in their studies of Rous sarcoma virus (RSV) vector RNAs.…”
The retroviral primary transcription product is a multifunctional RNA that is utilized as pre-mRNA, mRNA, and genomic RNA. The relationship between human immunodeficiency virus type 1 (HIV-1) unspliced transcripts used as mRNA for viral protein synthesis and as virion precursor RNA (vpRNA) for encapsidation remains an important question. We developed a biochemical assay to evaluate the hypothesis that prior utilization as mRNA template for protein synthesis is necessary to generate vpRNA. HIV-1-infected T cells were treated with translation inhibitors under conditions that maintain virus production. Immunoprecipitation of newly synthesized HIV-1 Gag protein revealed that de novo translation is not necessary to sustain assembly, release, or processing of Gag structural protein. Both newly synthesized protein and steady-state Gag are competent for assembly, and the extracellular accumulation of Gag is proportional to the intracellular abundance of Gag. As early as 2 h after transcription, newly synthesized RNA is detectable in cell-free virions and encapsidation is sustained upon inhibition of host cell translation. Results of both [ 3 H]uridine incorporation assays and HIV-1-specific RNase protection assays (RPAs) indicate that translation inhibition reduces the absolute amounts of both cytoplasmic and virion-associated RNA. Evaluation of encapsidation efficiency by RPA revealed that the cytoplasmic availability of vpRNA is increased, indicating that HIV-1 unspliced mRNA can be rerouted to function as vpRNA. Our data contrast with results from the HIV-2 and murine leukemia virus systems and indicate that HIV-1 unspliced RNA constitutes a single functional pool that can function interchangeably as mRNA and as vpRNA.
“…It is possible that U6 snRNA associates with multiple sites on the RSV genome. Evidence that RSV virion RNA can be translated prior to packaging (Stoltzfus et al 1983; J. LeBlanc and K. Beemon, unpubl. ) suggests that U6 snRNA is not associated with the efficiently translated leader region or the gag gene.…”
Retroviruses specifically package two copies of their RNA genome in each viral particle, along with some small cellular RNAs, including tRNAs and 7S L RNA. We show here that Rous sarcoma virus (RSV) also packages U6 snRNA at approximately one copy per virion. In addition, trace amounts of U1 and U2 snRNAs were detected in purified virus by Northern blotting. U6 snRNA comigrated with the RSV 70S genomic RNA dimer on sucrose gradients. We observed reverse transcription of U6 snRNA in an endogenous reaction in which RSV particles were the source of both reverse transcriptase and RNA substrates. This finding led us to examine mammalian genomic sequences for the presence of snRNA pseudogenes. A survey of the human, mouse, and rat genomes revealed a high number of spliceosomal snRNA pseudogenes. U6 pseudogenes were the most abundant, with approximately 200 copies in each genome. In the human genome, 67% of U6 snRNA pseudogenes, and a significant number of the other snRNA pseudogenes, were associated with LINE, SINE, or retroviral LTR repeat sequences. We propose that the packaging of snRNAs in retroviral particles leads to their reverse transcription in an infected cell and the integration of snRNA/viral recombinants into the host genome.
“…Through actD treatment of cells containing radiolabeled RNAs, Stoltzfus et al (44) determined the half-life of unspliced RSV RNAs to be 7.5 h both in the cytoplasm and in virions. Thus, they propose that RSV also employs a single population of RNAs to serve as genomic RNAs as well as mRNAs.…”
Retroviruses package full-length, unspliced RNAs into progeny virions as dimerized RNA genomes. They also use unspliced RNAs as mRNAs to produce the gag and pol gene products. We asked whether a single Rous sarcoma virus (RSV) RNA can be translated and subsequently packaged or whether genomic packaging requires a nontranslated population of RNAs. We addressed this issue by utilizing the translation-dependent nonsense-mediated mRNA decay (NMD) pathway. NMD is the selective destruction of mRNAs bearing premature termination codons (PTCs). The pathway has been shown to be associated with splicing in higher eukaryotes. Here, we demonstrate that both translation and the cellular factor Upf1 are required for the decay of unspliced, PTC-bearing RSV RNA by the NMD pathway. To address the relationship between RNA translation and packaging, we examined virus produced in cells cotransfected with PTC-bearing retroviral clones and wild-type viral clones. We observed that PTC-bearing transcripts are packaged into viral particles at levels three-to fivefold less than those of control RNAs. Since PTC-mediated degradation requires translation, we conclude that RSV can package progeny virion particles using previously translated RNAs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.